Education:
Mr. Baijot holds a PhD in molecular biology form the University of Louvain in Belgium.
Previous assignments / engagements:
He is a biochemist engineer and brings more than 25 years of experience from senior roles in the global biotechnology and vaccine industry of both developed and developing countries. His previous positions include Worldwide Vice President Strategy, Licensing & M&A at GSK Vaccines, Chief Business Officer at Janssen Crucell Vaccines, Executive Director Europe at Serum Institute of India, Board Director at Sinovac, Chairman at Radiomics, Corporate Director Molecular Diagnostics at bioMérieux.
Ongoing positions:
Mr. Baijot serves as Chairman at White Fund and at CuraVac, as Board Director at RNAlead and at Expres2ion Biotech, and as Advisor at Noshaq.
